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Abstract  
The aim of our study was to report the status of penile cancer sites in the urology department at the University Hospital of Rabat and evaluate 
long-term results of surgical treatment of this cancer. Patients and Methods: Between 1989 and 2015, 10 patients were treated for penile cancer. 
10 cases were retrospectively reviewed and the following data were recorded: mode of revelation, seat, staging, TNM stage, treatment, evolution 
and survival. The mean age of patients was 58,1 years (48-81 years). All patients had squamous cell carcinoma of the penis. Six patients had a 
partial amputation of the penis, and three patients underwent total amputation. The median size of the lesion was 4.25 cm (1.5-8 cm). All tumors 
had a distal seat (gland- Furrow balanopreputial), 8 were localized and non-invasive (PT1 - PT2) and 2 had infiltrated the urethra (PT3). Four 
patients had lymph node localization. A single bilateral lymphadenectomy was performed and was positive only on one side, with a node <3 cm 
and no extracapsular extension. Two patients were referred for chemotherapy, a neoadjuvant referred to basic (Bleomycin - Methotrexate, 
Cisplatin) the other in a palliative goal. Median follow-up was 42 months (6 -72mois). Four patients died, one of which was presented immediately 
with metastatic mode. Six patients were alive at last node or local recurrence negative. Cancer of the penis seems rare in Morocco. His oncologic 
and functional outcomes (sexual and urinary) depend on the precocity of the treatment. The surgery of lymph node resection with 
lymphadenectomy remains the reference treatment. 
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Tumors of the penis are the rarest tumors of the genitourinary 
system, it represents 0.5% of malignant tumors of man [1]. Penile 
carcinoma is mostly a squamous cell carcinoma (SCC) but other 
types of carcinoma exist as well [2]. The incidence of penile cancer 
increases with age [3], with an age peak during the sixth decade of 
life. However, the disease does occur in younger men.  
  
Several risk factors for penile cancer have been identified by a 
review of the literature published since 1966.One of the most 
important risk factor for developing penile canceris the Human 
papilloma virus infection. It seems that neonatal circumcision 
reduces the incidence of penile cancer in countries and cultures 
where this is routinely practiced. Squamous cell carcinoma can have 
several clinical aspects: ulcerating or budding, localized or invading 
the whole structure of the penis.  
  
To appreciate the evolution and expansion of these tumors, several 
diagnostic tests have been proposed: Ultrasound, CT or MRI and 
more recently FDG-positron emission tomography. There are a 
variety of treatment modalities for the penile cancer and are always 
adapted to TNM stage, tumor grade. The prognosis is pejorative: 





This is a retrospective study interesting ten patients. The following 
data were recorded: history, diagnosis, mode of revelation, the seat 
height, balance sheet preparation extension stage (TNM 2009), 
rank, the margin of resection and therapeutic attitude tick. The 
patients were seen every 3 months during the first year and then 





Patient characteristics were detailed in Table 1. The mean age at 
diagnosis was 58,1 years (46-81 years). The mode of revelation in 
all patients was the presence of a macroscopic lesion (Figure 1), 
the median tumor size was 5,1cm (1.5-8 cm). All tumors had a 
distal seat (gland- Furrow balano- preputial), 8 were located and 
non-invasive (pT1 - pT2) and 2 infiltrated the urethra (pT3) (Figure 
2). Three patients had lymph node localization. One of the patients 
had T3 emblem of inguinal lymph node metastases and liver 
metastases. Tumor grade was always ? 2. Nine patients underwent 
surgical treatment for early amputation of the penis or partial 
penectomy (Figure 3, Figure 4, Figure 5). Two patients were 
referred for chemotherapy, a neo referred based adjuvants 
(Bleomycin - Methotrexate, Cisplatin) the other in a palliative goal. 






The average age of cancer diagnosis in our study (58,1 years) is 
consistent with the literature: incidence maximum occurs after 50 
years [3]. The location was most often distal (prepuce and glans) 
according to what is described. One of the most important risk 
factor for developing penile cancer is the Human papilloma virus 
infection. It has been identified in 70-100% of intraepithelial 
neoplasia and in 30-40% of invasive penile cancer tissue samples 
[4] HPV subtypes most commonly found in penile cancer are types 
16 and 18 [5] (Figure 6, Figure 7).  
  
Penile carcinoma is most frequent in uncircumcised males than in 
those circumcised in infancy, for example: Non-Jewish versus 
Jewish population in the West and non-Muslim versus Muslim 
population in India [6]. Circumcision at birth however, does not 
always protect an individual from developing penile cancer.Also 
circumcision beyond infancy is also not protective against the 
development of penile cancer [7]. An other risk factor of the 
development of invasive penile cancer is the Phimosis [8], probably 
due to associated chronic infection. A further risk factor suggested 
by epidemiological studies is cigarette smoking, which is associated 
with a 4.5-fold increased risk (95%) [9].  
  
Low socio-economic status and a low level of education are other 
epidemiological factors associated with penile cancer. In our study, 
only two cases of HPV have been diagnosed on biopsy by the 
presence of malpigiennes cells infected with the virus who take an 
aspect quite pathognomonic called koilocyte (large cells with 
vacuolated cytoplasm with enlarged nuclei and hyperplastic 
sometimes multinucleated).  
  
Squamous cell carcinoma accounts for more than 95% of cases of 
malignant diseases of the penis. Other malignant lesions of the 
penis unrelated to penile SCC are melanocytic lesions, 
mesenchymaltumours, lymphomas and secondary tumours, i.e. 
metastases. These are all much less common than penile SCC. 
Aggressive sarcoma of different types occurring in the penis have 
been reported.  
  
In our study assessing the local expansion of the penis was based 
on the penis examination and ultrasound. Ultrasound can give 
information about infiltration of the corpora [10]. Magnetic 
resonance imaging (MRI) in combination with an artificial erection 
with prostaglandin E 1 can also be used for excluding tumour 
invasion of the corpora cavernosa if organ-preservation is planned 
and preoperative decisions are needed [11].  
  
All patients had a deep biopsy for histological confirmation and 
appreciation of the depth of infiltration. The areas of palpation for 
lymph node assessmentshould be systematic and bilateral. If 
lymphadenopathy palpated, we should do a needle aspiration 
cytology of (the) node (s), associated with ultrasound guidance. She 
increased the micrometastases detection rates in the sentinel lymph 
node biopsy but few expert center used in practice. When the 
clinical examination is difficult (obese patients) or if clinical inguinal 
lymph node involvement (evaluation of pelvic areas) Inguinal and 
pelvic CT scan isrecommended. It is important to notice that there is 
no pelvic lymph node involvement that has been demonstrated 
without inguinal lymph node involvement [12].  
  
The imagery is not essential for normal inguinal lymphadenopathy 
area without palpated. All patients had at least one abdominopelvic 
CT scan to define the nodal status in the most comprehensive way 
possible, but one for which an MRI was performed. MRI has proven 
superior to CT in the detection of inguinal lymph nodes. The sentinel 
node was most effective in patients CN0 that cN +. It is not 
recommended in patients with a palpable lymphadenopathy. The 
nodal risk is material and requires care in case of penile tumor ? 
pT1bG2 or when palpated adenopathy [13].  
  
An assessment of distant metastases should be performed in 
patients with positive inguinal nodes. There is no established 
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tumour marker for penile cancer. Regarding surgical treatment, six 
patients with pT1 N0 M0 tumor site in the glans had a partial 
penectomy, the other three pT2 N2 M0, pT2 N1 M0, pT3 N0 M0 
have experienced a complete amputation with negative margins. 
The last one had a palliative chemo. So following the 
recommendations of CCAFU, patients with infiltrating lesions ? PT2 
had surgery by partial or total penectomy. In case of partial 
amputation, the length of the remaining penis must be at least 3cm 
[14].  
  
In clinically lymph-node positive patients, surgical staging by 
inguinal lymphadenectomy is indicated. Radical inguinal 
lymphadenectomy carries a significant morbidity related to problems 
of lymph drainage from the legs and wound healing. While 
morbidity can be as high as 50% [15]. Wound infections (1.2-
1.4%), skin necrosis (0.6-4.7%) lymphedema (5-13.9%) and 
lymphocele formation (2.1-4%) were the most commonly reported 
complications in recent series. Therapeutic radical inguinal 
lymphadenectomy can be life-saving but it may be underused for 
fear of associated morbidity [16]. The superficial inguinal 
lymphadenectomy modified involves ablation of superficial inguinal 
nodes located medial to the great saphenous vein [17]. Morbidity is 
low at about 6.8% of early complications and 3.4% of late 
complications [18]. If a modified inguinal lymphadenectomy is 
performed and confirmed lymph node involvement (or 
extemporaneous final review), it should always be taken for 
totalization (lymphadenectomy).  
  
In our study, we performed a single bilateral inguinal lymph node 
dissection, the dissection was negative right and left we found a 
single node metastases <3 cm without capsular which did not 
require a pelvic lymphadenectomy ipsilateral metastasis is 
recommended if there are more than two nodes or metastasized to 
a lymph node capsular.  
  
Cancer of the penis is a little chemo-sensitive tumor chemotherapy 
and no product has the marketing authorization (MA) for use in 
cancer of the penis. Overall, the results of neoadjuvant or adjuvant 
chemotherapy does not suggest the interest on survival and local 
control, given the small number of cases in the series and the 
absence of randomization.  
  
Two of our patients were referred for chemotherapy, one 
(pT2N2M0) to neoadjuvant referred to basic (Bleomycin - 
Methotrexate, Cisplatin) in the general condition does not allow to 
make a inguinal lymphadenectomy, the other (pT3N3M + ) in a 
palliative goal.There is no consensus in the manner and frequency 
of monitoring. The follow-up interval and strategies for patients with 
penile cancer are directed by the initial treatment of the primary 
lesion and regional lymph nodes. In a multicentre study, during the 
first two years 74.3% of all recurrences, 66.4% of local recurrences, 
86.1% of regional recurrences and 100% of distant recurrences 
were detected. In the same study, 92.2% of all recurrences 
occurred within the first 5 years and all recurrences seen after 5 
years were local recurrences or new primary lesions. Therefore, an 
intensive follow-up regimen during the first 2 years is rational, with 
less intensive follow- up needed thereafter for a minimum of 5 
years. Generally, follow-up should continue thereafter but may be 
omitted in well-educated and motivated patients who reliably 
continue to carry out regular self-examination [19].  
  
Our patients had clinical monitoring penile and lymph nodes, 
quarterly in the first year and then every six months in the absence 





The low incidence of penile tumors in the general population 
remains a real obstacle to the publication of consistent series of 
patients likely to generate well codified therapeutic management. 
Human papilloma virus infection is an important risk factor for 
developing penile cancer. Neonatal circumcision reduces the 
incidence of penile cancer. The treatment of cancers of the penis is 
usually surgical roughly in combination with chemotherapy in the 
case of lymph node. The main prognostic factor is lymph node 
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Table 1: main characteristics of patients 
  P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 


















glans glans body glans glans glans glans 
size 1,5 cm 5 cm 3 cm 4 cm 5 cm 8 cm 3 cm 3 cm 4 cm 6 cm 
PT PT1 PT2 pT2 PT1 PT1 PT3 PT1 PT1 PT1 PT3 
N N0 N2 N1 N0 N0 N3 N0 N0 N1 N0 
M M0 M0 M0 M0 M0 M+ M0 M0 M0 M0 
G 1 2 1 1 1 - 1 1 1 2 
Emboli V/L V0 - V0/LO - - - - - - - 
Preoperativeassessment CT CT MRI CT CT CT CT CT CT CT 
Precancerous lesion or 
HPV infection 
+ - - - - - - - - + 
























follow 5 years 1 year 3 years 5 years 6 years 
6 
mounths 
4 years 5 years 2 years - 
recidivism no no No no no no no no no - 
death yes yes Yes no no yes no no no no 
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Figure 3: Appearance after total penectomy  
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Figure 7: Cutaneous coatings adjacent to the tumor showing parakeratosis. Koilocytespresence 
(HEx200) 
 
